Publication | Open Access
A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR)
16
Citations
21
References
2024
Year
ClinicalTrials.gov: NCT06059014.
| Year | Citations | |
|---|---|---|
Page 1
Page 1